Trial Profile
A randomized, double-blind, placebo controlled, multi-center, pilot study to evaluate the safety and analgesic activity of M40403 co-administered with an opioid agent in a cancer pain model
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Aug 2006
Price :
$35
*
At a glance
- Drugs Imisopasem manganese (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 15 Aug 2006 Status change
- 18 Oct 2005 New trial record.